Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

eotaxin-3 Inhibitors

Eotaxin-3, a member of the eotaxin subfamily of chemokines, plays a pivotal role in the immune system's orchestration, particularly in mediating the recruitment and activation of eosinophils. This chemokine is primarily associated with the pathophysiology of various allergic and inflammatory conditions, including asthma, atopic dermatitis, and eosinophilic esophagitis. By binding specifically to the CCR3 receptor on eosinophils, eotaxin-3 facilitates the migration of these cells to sites of inflammation, contributing to the inflammatory response and tissue remodeling observed in allergic diseases. The regulation of eotaxin-3 is intricately linked to various signaling pathways and transcription factors, responding to a wide array of cytokines and inflammatory stimuli. This regulation underscores the complexity of its role in immune responses, highlighting the chemokine's importance in maintaining the balance between protective and pathological immune reactions. The specificity of eotaxin-3's action on eosinophils makes it a significant target for understanding and modulating eosinophilic inflammation, with its inhibition presenting a potential strategy for controlling excessive eosinophil recruitment and activation. The inhibition of eotaxin-3, given its crucial role in eosinophilic inflammation, can be approached through indirect mechanisms focusing on the modulation of signaling pathways and transcriptional regulation that influence its expression and activity. These mechanisms entail targeting upstream modulators such as NF-κB, a key transcription factor in the regulation of inflammatory genes, or signaling pathways like MAPK, JAK/STAT, and others involved in cellular stress responses and inflammation. By influencing these pathways, it is possible to modulate the cellular environment and transcriptional activity that govern eotaxin-3 expression, thereby indirectly affecting its levels and activity. This strategy leverages the interconnected nature of cellular signaling networks to achieve a dampening effect on eotaxin-3, aiming to mitigate its role in eosinophil recruitment and the subsequent inflammatory cascade.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Apocynin

498-02-2sc-203321
sc-203321A
sc-203321B
sc-203321C
1 g
10 g
100 g
500 g
$27.00
$68.00
$116.00
$360.00
74
(2)

Apocynin inhibits NADPH oxidase, reducing reactive oxygen species production. This action can decrease inflammatory signaling pathways that upregulate eotaxin-3 expression, thus indirectly inhibiting its activity by lowering its expression in inflamed tissues.

Zileuton

111406-87-2sc-204417
sc-204417A
sc-204417B
sc-204417C
10 mg
50 mg
1 g
75 g
$84.00
$307.00
$369.00
$1254.00
8
(1)

Zileuton, a 5-lipoxygenase inhibitor, reduces leukotriene production, a key mediator in eosinophilic inflammation. By diminishing leukotriene levels, zileuton may indirectly lower eotaxin-3 activity by attenuating the inflammatory environment that stimulates its expression.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin modulates multiple signaling pathways, including NF-κB, which is implicated in the transcriptional regulation of eotaxin-3. Through its anti-inflammatory properties, curcumin could indirectly reduce eotaxin-3 expression by inhibiting NF-κB activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol suppresses the activation of NF-κB and AP-1, both of which are involved in the expression of eotaxin-3. By modulating these transcription factors, resveratrol may indirectly inhibit eotaxin-3 expression in inflammatory conditions.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin, a flavonoid, inhibits the JAK/STAT pathway, which can be involved in the regulation of eotaxin-3 expression. Its anti-inflammatory effects might indirectly reduce eotaxin-3 levels by dampening the pathway that enhances its expression.

Wogonin, S. baicalensis

632-85-9sc-203313
10 mg
$200.00
8
(1)

Wogonin, a flavonoid derived from Scutellaria baicalensis, inhibits the STAT3 signaling pathway, potentially affecting eotaxin-3 expression. By modulating this pathway, wogonin could indirectly decrease eotaxin-3 levels and its mediated eosinophil recruitment.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an MEK inhibitor that indirectly may influence eotaxin-3 by affecting the MAPK/ERK pathway, involved in cell proliferation and inflammatory responses. Inhibition of this pathway could lead to reduced eotaxin-3 expression in inflammatory settings.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, potentially reducing eotaxin-3 expression by inhibiting the pathway involved in stress response and inflammation. By targeting this pathway, SB203580 might indirectly suppress eotaxin-3 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, which may indirectly reduce eotaxin-3 levels by modulating the JNK pathway involved in inflammatory and stress responses. This could lead to decreased expression of eotaxin-3 in inflammatory conditions.

Andrographolide

5508-58-7sc-205594
sc-205594A
50 mg
100 mg
$15.00
$40.00
7
(1)

Andrographolide targets NF-κB, a key regulator of inflammation and eotaxin-3 expression. By inhibiting NF-κB, andrographolide could indirectly suppress eotaxin-3 levels, thereby modulating the inflammatory response.